Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2531-2540 of 2870 for cancer

Edit search filters
  1. A Study To Explore If It Is Possible To Successfully Obtain Optical Coherence Tomography (OCT) Imaging And Data While Patients Undergo Brain Surgery

    Jacksonville, FL

  2. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Circulating Tumor Nucleic Acids To Monitor Treatment Response In Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

  4. Blood Brain Barrier Differences In Patients With Brain Tumors Undergoing Surgery

    Rochester, MN

  5. Ultrasound Microvessel Imaging For Differentiation Of Ocular Tumors

    Rochester, MN

  6. Natural History of Brain Function, Quality of Life, and Seizure Control in Patients with Brain Tumor Who Have Undergone Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. A Study of BI-RADS 4 and 5 Lesions that are Malignant and Increased Stiffness on MR Elastography Compared to Lesions that are Benign

    Rochester, MN

  8. Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

    Rochester, MN

  9. A Study Of DNA Markers For The Detection Of Metastatic Melanoma In Blood

    Rochester, MN

  10. Effect of Agent Orange Exposure on Endocrine Tumor Aggressiveness

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer